2238 Sato, Takami - Thomas Jefferson University - Thomas Jefferson University
Dr. Sato

Takami Sato, MD, Ph.D

Contact Dr. Sato

925 Chestnut Street
Suite 320A
Philadelphia, PA 19107

(215) 955-8874

Most Recent Peer-reviewed Publications

  1. Double-Blinded, Randomized Phase II Study Using Embolization with or without Granulocyte-Macrophage Colony-Stimulating Factor in Uveal Melanoma with Hepatic Metastases
  2. Expression of insulin-like growth factor-1 receptor in metastatic uveal melanoma and implications for potential autocrine and paracrine tumor cell growth
  3. Tumor necrosis factor-α blockade and development of uveal melanoma: Expected adverse effect or just coincidence?
  4. Early arterial stasis during resin-based yttrium-90 radioembolization: Incidence and preliminary outcomes
  5. The potential role of sunitinib targeting melanomas
  6. Somatostatin receptor scintigraphy in patients with metastatic uveal melanoma
  7. A pilot study of sunitinib malate in patients with metastatic uveal melanoma
  8. Uveal melanoma trapped in the temple of doom
  9. Interleukin 6 mediates production of interleukin 10 in metastatic melanoma
  10. Lymph node ratio is an important and independent prognostic factor for patients with stage III melanoma
  11. Interleukin 10 in the tumor microenvironment: A target for anticancer immunotherapy
  12. Toxicities after radioembolization with yttrium-90 SIR-spheres: Incidence and contributing risk factors at a single center
  13. Moxifloxacin prophylaxis for chemoembolization or embolization in patients with previous biliary interventions: A pilot study
  14. Side-branch embolization before 90Y radioembolization: Rate of recanalization and new collateral development
  15. Tumor-derived interleukin-10 as a prognostic factor in stage III patients undergoing adjuvant treatment with an autologous melanoma cell vaccine
  16. Summary and assessment
  17. A phase 1-2 study of imexon plus dacarbazine in patients with unresectable metastatic melanoma
  18. Surgically unresectable regional melanoma metastases in a patient with renal failure and peripheral vascular disease: Are there safe and potentially effective treatments?
  19. Locoregional Management of Hepatic Metastasis From Primary Uveal Melanoma
  20. Human interleukin 10 receptor 1/IgG1-Fc fusion proteins: Immunoadhesins for human IL-10 with therapeutic potential
0